Carvedilol (as phosphate) 10mg, 20mg, 40mg, 80mg; ext-rel caps. Coreg CR are supplied as hard gelatin capsules in bottles of 30 in the following strengths: 10 mg – white and green capsule shell ...

Flamel might be earning more than had been calculated from its lead drug, but the company still isn't profitable. Flamel gets royalties from sales of heart-disease drug Coreg CR, which it helped ...

Following a more than decade-long legal back-and-forth over the generic drug carveout practice known as “skinny” labeling, GSK and Teva have put their dispute to bed, new court documents show. In a ...

The first generic versions of GlaxoSmithKline’s cardiovascular agent Coreg – all 14 of them – have been approved by US regulators. The first generic versions of GlaxoSmithKline’s cardiovascular agent ...

Please provide your email address to receive an email when new articles are posted on . Two preparations of carvedilol given to patients with heart failure were found nearly bioequivalent. Researchers ...

Prove it, GlaxoSmithKline. So says a judge in the Coreg patent case that last year ended in a $235 million judgment against generics maker Teva. In the patent "carve-out" case, GSK didn't bring enough ...

November 17, 2006 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise on the use of carvedilol tablets in diabetic patients; the risk for potentially fatal ...

Philadelphia, PA - The US Food and Drug Administration has approved a once-daily form of the beta blocker carvedilol (Coreg CR) for the treatment of patients with hypertension, postinfarction LV ...

Carvedilol is a generic prescription drug that’s used to treat high blood pressure and certain heart conditions. Carvedilol oral tablets are also available as the brand-name drug Coreg. Carvedilol is ...

The US Food and Drug Administration has approved a label update for GlaxoSmithKline’s Coreg (carvedilol), meaning that the beta-blocker is now available to reduce the risk of suffering a heart attack.

TRENTON, N.J. Teva has sued Apotex to prevent it from selling a generic version of the heart medication Coreg, according to Bloomberg. The two companies, as well as other generic drug makers, received ...